Preservation of hearing in partial deafness patients who received two different regimes of corticosteroid therapy following cochlear implantation
one-year observations
DOI:
https://doi.org/10.1590/s2175-97902022e20358Keywords:
Off-label use, Intensive Care Units, Critical Care, High-alert medicationAbstract
The objective of this study was to assess how different modes of steroid therapy affect hearing preservation in Partial Deafness Treatment group of patients. In this study, the group consisted of 46 (24 women, 22 men; aged 18-78 years) cochlear implant patients divided into 3 subgroups. In the first subgroup (N = 13), patients underwent standard intravenous (IV) steroid therapy following implantation. In the second (N = 16), patients underwent prolonged treatment with a combination of oral and IV corticosteroids. Third subgroup (N = 17) was a control group who received no steroids therapy. The mean hearing preservation rate was 52.1% (SD = 36.7) in patients receiving standard steroid therapy, 71.4% (SD = 22.7) in patients with prolonged steroid therapy, and 22.1% (SD = 33.9) in control patients. The smallest variation of hearing preservation rate was observed in patients with prolonged steroid therapy and was 9.9 dB. In comparison, the mean change in patients with standard steroid therapy was 11.7 dB and for control patients the figure was 18.0 dB. A combination of intravenous and oral steroid therapy seems to be optimal and stabilizes hearing thresholds and preserves hearing.
Downloads
References
Alles MJRC, der Gaag MA, Stokroos RJ. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol. 2006;263(9):791-797.
Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci Lond Engl. 1998;94(6):557-572.
Beato M, Truss M, Chávez S. Control of transcription by steroid hormones. Ann N Y Acad Sci. 1996;784:93-123.
Brown CJ, Abbas PJ, Bertschy M, Tyler RS, Lowder M, Takahashi G, et al.Longitudinal assessment of physiological and psychophysical measures in cochlear implant users. Ear Hear. 1995;16(5):439-449.
Brunton L, Knollman B, Hilal-Dandan R. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 13th Edition. New York: McGraw-Hill Education / Medical, 2017.
Cho HS, Lee K-Y, Choi H, Jang JH, Lee SH. Dexamethasone is one of the factors minimizing the inner ear damage from electrode insertion in cochlear implantation. Audiol Neurootol. 2016;21(3):178-186.
Chrousos GP. Adrenocorticosteroids & adrenocortical antagonists, in: Basic & Clinical Pharmacology. New York: The McGraw-Hill Companies Inc. 2007.
Creber NJ, Eastwood HT, Hampson AJ, Tan J, O’Leary SJ. Adjuvant agents enhance round window membrane permeability to dexamethasone and modulate basal to apical cochlear gradients. Eur J Pharm Sci. 2019;126:69-81.
Dixon PR, Shipp D, Smilsky K, Lin VY, Le T, Chen JM. Association of speech processor technology and speech recognition outcomes in adult cochlear implant users. Otol. Neurotol. 2019;40(5):595-601.
Douchement D, Terranti A, Lamblin J, Salleron J, Siepmann F, Siepmann J, et al. Dexamethasone eluting electrodes for cochlear implantation: Effect on residual hearing. Cochlear Implants Int. 2015;16(4):195-200.
Fontenot TE, Giardina CK, Dillon M, Rooth MA, Teagle HF, Park LR, et al. Residual Cochlear Function in Adults and Children Receiving Cochlear Implants: Correlations With Speech Perception Outcomes. Ear Hear . 2019;40(3):577-591.
Hamid M, Trune D. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg. 2008;16(5):434-440.
Honeder C, Zhu C, Schöpper H, Gausterer JC, Walter M, Landegger LD, et al. Effects of sustained release dexamethasone hydrogels in hearing preservation cochlear implantation. Hear Res. 2016;341:43-49.
Lorens A, Kruszyńska M, Obrycka A, Skarzynski PH, Wilson B, Skarzynski H. 2019. Binaural advantages in using a cochlear implant for adults with profound unilateral hearing loss. Acta Otolaryngol. (Stockh.). 2019;139(2):153-161.
Lyu A-R, Kim DH, Lee SH, Shin D-S, Shin S-A, Park Y-H. Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes. PloS One. 2018;13(3):e0195230.
Murillo-Cuesta S, Vallecillo N, Cediel R, Celaya AM, Lassaletta L, Varela-Nieto I, et al.A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection. J Vis Exp. 2017;(121):54951.
Nguyen S, Cloutier F, Philippon D, Côté M, Bussières R, Backous DD. Outcomes review of modern hearing preservation technique in cochlear implant. Auris Nasus Larynx. 2016;43(5):485-488.
Nyberg S, Abbott NJ, Shi X, Steyger PS, Dabdoub A. Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier. Sci Transl Med. 2019;11(482). pii: eaao0935.
Pierstorff E, Chen S, Chaparro MP, Cortez JM, Chen Y-J, Ryu SY, et al. A Polymer-based extended release system for stable, long-term intracochlear drug delivery. Otol Neurotol. 2018;39(9):1195-1202.
Plontke SK, Götze G, Rahne T, Liebau A. Intracochlear drug delivery in combination with cochlear implants: Current aspects. HNO. 2017;65( Suppl 1):19-28.
Rah YC, Lee MY, Kim SH, Kim DH, Eastwood H, O’Leary SJ, et al.Extended use of systemic steroid is beneficial in preserving hearing in guinea pigs after cochlear implant. Acta Otolaryngol (Stockh.). 2016;136(12):1213-1219.
Ramos Macías Á, Borkoski-Barreiro SA, Falcón González JC, de Miguel Martínez I, Ramos de Miguel Á. Single-sided deafness and cochlear implantation in congenital and acquired hearing loss in children. Clin Otolaryngol. 2019;44(2):138-143.
Salt AN, Plontke SK. Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications. Hear Res . 2018;368:28-40.
Sarant J, Harris D, Busby P, Maruff P, Schembri A, Dowell R, et al. The Effect of cochlear implants on cognitive function in older adults: initial baseline and 18-month follow up results for a prospective international longitudinal study. Front Neurosci. 2019;13:789.
Skarżyńska MB, Skarżyński PH, Król B, Kozieł M, Osińska K, Gos E, et al. Preservation of hearing following cochlear implantation using different steroid therapy regimens: A prospective clinical study. Med Sci Monit. 2018;24:2437-2445.
Skarzynski H, Lorens A, Piotrowska A, Skarzynski PH. Hearing preservation in partial deafness treatment. Med Sci Monit. 2010;16(11):CR555-562.
Skarżyński H, Lorens A, Skarżyński PH. Electro-Natural Stimulation (ENS) in Partial Deafness Treatment: A case study. J Hear Sci. 2014;4(4):67-71.
Skarzynski H, Matusiak M, Lorens A, Furmanek M, Pilka A, Skarzynski PH. Preservation of cochlear structures and hearing when using the Nucleus Slim Straight (CI422) electrode in children. J Laryngol Otol. 2016;130(4):332-339.
Skarzynski H, Matusiak M, Piotrowska A, Skarzynski PH. Surgical techniques in partial deafness. J Hear Sci. 2012;2(3):9-13.
Skarzynski H, van de Heyning P, Agrawal S, Arauz SL, Atlas M, Baumgartner W, et al. Towards a consensus on a hearing preservation classification system. Acta Otolaryngol. Suppl. 2013;(564):3-13.
Smoak KA, Cidlowski JA. Mechanisms of glucocorticoid receptor signaling during inflammation. Mech Ageing Dev. 2004;125(10-11):697-706.
Sosna M, Tacikowska G, Pietrasik K, Skarżyński H, Lorens A, Skarżyński PH. Effect on vestibular function of cochlear implantation by partial deafness treatment-electro acoustic stimulation (PDT-EAS). Eur Arch Otorhinolaryngol . 2019;276(7):1951-1959.
Stuermer KJ, Kluenter HD, Lang-Roth R, Schwarz D, Hüttenbrink K-B, Anagiotos A. Preservation of Vestibular Function and Residual Hearing After Round Window Cochlear Implantation. Otol Neurotol . 2019;40(7):878-882.
Sweeney AD, Carlson ML, Zuniga MG, Bennett ML, Wanna GB, Haynes DS, et al. Impact of perioperative oral steroid use on low-frequency hearing preservation after cochlear implantation. Otol Neurotol . 2015;36(9):1480-1485.
Teschner M, Polite C, Lenarz T, Lustig L. Cochlear implantation in different health-care systems: disparities between Germany and the United States. Otol Neurotol . 2013;34(1):66-74.
Usami S-I, Moteki H, Suzuki N, Fukuoka H, Miyagawa M, Nishio S-Y, et al.Achievement of hearing preservation in the presence of an electrode covering the residual hearing region. Acta Otolaryngol. (Stockh.) 2011;131(4):405-412.
Van Abel KM, Dunn CC, Sladen DP, Oleson JJ, Beatty CW, Neff BA, et al. Hearing preservation among patients undergoing cochlear implantation. Otol Neurotol. 2015;36(3):416-421.
Webster JC, Cidlowski JA. Mechanisms of Glucocorticoid-receptor-mediated Repression of Gene Expression. Trends Endocrinol Metab. 1999;10(10):396-402.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
